Print Page     Close Window     

SEC Filings

10-Q
BIOTIME INC filed this Form 10-Q on 08/09/2017
Entire Document
 

Signature Page

[Second Amended and Restated Research and License Agreement]

IN WITNESS WHEREOF, the Parties hereto have duly executed this Agreement as of the Effective Date.
 
/s/ Charles S. Irving
 
 CELL CURE NEUROSCIENCES LTD.
 
By:
Dr. Charles S. Irving
Title:
C.E.O.
Date:
 
 
/s/ Tamar Raz
/s/ Carole Grumbach
HADASIT MEDICAL RESEARCH SERVICES AND DEVELOPMENT LTD.

By:
Tamar Raz
Title:
C.E.O.
Date:
 

By:
Carole Grumbach
Title:
VP Finance & Contracts
Date:
 

I hereby confirm that I will abide by the instructions issued to me by Hadasit pursuant to Section 7.5 of the Agreement and to the provisions of Section 11.7 of this Agreement.
 
/s/[ * ]
 
[ * ]
 
Date:
   

[ * ] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.
 
- 37 -

© Copyright BioTime, Inc.